Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Protalix Biotherapeutics (PLX)

Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Protalix Biotherapeutics 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601 USA

www.protalix.com Employees: 213 P: 201-696-9345

Sector:

Medical

Description:

Protalix BioTherapeutics Inc. is a biopharmaceutical company. It is focused on the development and commercialization of recombinant therapeutic proteins. The company's product pipeline includes ProCellEx(R). Protalix BioTherapeutics Inc. is based in CARMIEL, Israel.

Key Statistics

Overview:

Market Capitalization, $K 141,541
Enterprise Value, $K 121,781
Shares Outstanding, K 80,421
Annual Sales, $ 53,400 K
Annual Net Income, $ 2,930 K
Last Quarter Sales, $ 17,850 K
Last Quarter Net Income, $ 2,360 K
EBIT, $ 6,360 K
EBITDA, $ 7,660 K
60-Month Beta -0.25
% of Insider Shareholders 6.50%
% of Institutional Shareholders 16.53%
Float, K 75,194
% Float 93.50%
Short Interest 4,157
Short Float 5.17%
Short Volume Ratio 0.46

Growth:

1-Year Return 5.26%
3-Year Return 52.54%
5-Year Return -47.67%
5-Year Revenue Growth -2.36%
5-Year Earnings Growth 103.25%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.03 on 11/13/25
Next Earnings Date 03/16/26
Earnings Per Share ttm 0.07
EPS Growth vs. Prev Year 0.00%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 12/20/19

PLX Ratios

Ratio
Price/Earnings ttm 25.86
Price/Earnings forward 72.40
Price/Earnings to Growth N/A
Return-on-Equity % 11.28%
Return-on-Assets % 7.00%
Profit Margin % 5.49%
Debt/Equity 0.00
Price/Sales 2.73
Price/Cash Flow 31.46
Price/Book 2.73
Book Value/Share 0.66
Interest Coverage -1.34
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar